Life Sciences - Page 29 - Research Triangle Regional Partnership

As FDA authorizes plasma to combat COVID-19, Clayton plant working on possible treatment

August 24, 2020

CLAYTON – President Donald Trump announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called…

August 21, 2020

RESEARCH TRIANGLE PARK – IMMvention Therapeutix almost hit The Big Pitch out of the park. Almost. The 4-year-old Durham company,…

August 20, 2020

RESEARCH TRIANGLE PARK – Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the…

August 19, 2020

RESEARCH TRIANGLE PARK – G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory…

August 16, 2020

Novavax Inc. has locked in a deal to provide 60 million doses of its Covid-19 vaccine to the United Kingdom,…

August 14, 2020

Coming fresh off a $200 million raise, a drugmaker with a growing operation in the Triangle has received the go-ahead…

August 13, 2020

A Raleigh drugmaker pushing ahead with development of its drug portfolio has signed a series of deals with an Irish…

August 12, 2020

RESEARCH TRIANGLE PARK – A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell…

August 12, 2020

RALEIGH — Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83…